Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Ann Arbor
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Ann Arbor, MI

Studies commonly pay $75 to $4,500 per completed study

1,187 clinical trials are currently recruiting participants within 30 miles of Ann Arbor. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,187studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Ann Arbor right now

Top 25 of 1,187 recruiting studies, sorted by proximity — each links to its official registry page

One-Time DNA Study for Vasculitis

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis N/A Observational 1,000 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi) · Sponsor: University of Pennsylvania
See eligibility & contact on ClinicalTrials.gov (NCT01241305)

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
C.S. Mott Children's Hospital — Ann Arbor, Michigan (0.5 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05096481)

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought
University of Michigan Medical School — Ann Arbor, Michigan (0.5 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
See eligibility & contact on ClinicalTrials.gov (NCT05500807)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
C S Mott Children's Hospital — Ann Arbor, Michigan (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

Thrombocythemia, Essential, Primary Myelofibrosis Phase 3 Interventional 400 participants sought
University of Michigan ( Site 6000) — Ann Arbor, Michigan (0.5 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06351631)

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 120 participants sought
Detroit Clinical Research Center — Farmington Hills, Michigan (23.1 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06465329)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07007312)

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

Neuroblastoma Recurrent Phase 2 Interventional 54 participants sought
Motts Childrens Hospital — Ann Arbor, Michigan (0.5 mi) · Sponsor: St. Jude Children's Research Hospital
See eligibility & contact on ClinicalTrials.gov (NCT07085338)

A Study of the TheraBionic P1 Device in Breast Cancer

Breast Cancer Stage I, Breast Cancer Stage II N/A Interventional 24 participants sought
Karmanos Cancer Institute Weisberg Cancer Treatment Center — Farmington Hills, Michigan (23.1 mi) · Sponsor: Barbara Ann Karmanos Cancer Institute
See eligibility & contact on ClinicalTrials.gov (NCT07218432)

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

Amyotrophic Lateral Sclerosis, Neuromuscular Disease N/A Interventional 2 participants sought
University of Michigan — Ann Arbor, Michigan (0.5 mi) · Sponsor: Paradromics
See eligibility & contact on ClinicalTrials.gov (NCT07357428)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Trinity Health Saint Joseph Mercy Hospital Ann Arbor — Ann Arbor, Michigan (0.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis Phase 2 Interventional 164 participants sought
WISPer Site in Ann Arbor, MI — Ann Arbor, Michigan (0.5 mi) · Sponsor: Mediar Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06967805)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Ann Arbor, Michigan (0.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

Hypertension, Pulmonary, Lung Diseases, Interstitial Phase 2 Interventional 25 participants sought
Allen Park — Allen Park, Michigan (26.6 mi) · Sponsor: Tectonic Operating Company, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07473700)

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Dravet Syndrome Phase 1, Phase 2 Interventional 32 participants sought
University of Michigan Health System — Ann Arbor, Michigan (0.5 mi) · Sponsor: Ionis Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07531745)

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

Delirium, Neurocognitive Disorders N/A Interventional 1,900 participants sought
Michigan Medicine — Ann Arbor, Michigan (0.5 mi) · Sponsor: University of Michigan
See eligibility & contact on ClinicalTrials.gov (NCT05929703)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Ann Arbor, Michigan (0.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)
Actively enrolling

Studies you may be able to join near Ann Arbor

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Ann Arbor

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Michigan Institute for Clinical & Health Research

★ 5.0
1600 Huron Pkwy, Ann Arbor, MI 48105
(734) 998-7474

Early Treatment Center | Michigan Clinical Research Institute PC

3001 Plymouth Rd #107, Ann Arbor, MI 48105
(734) 834-8954

U of M Hospital Clinical Research, Kathryn Steen, MA, BS, TLLP Coordinator Department of Neurology

★ 5.0
1500 E Medical Center Dr Spc 5028, Ann Arbor, MI 48109
(734) 763-9909
"Anyone and everyone will help you to get you were your going. The place is amazing."
— Linda Mossner, 5★

UMich Center for the History of Medicine

102 Observatory St Room 100, Ann Arbor, MI 48109

Center for Bioethics and Social Sciences in Medicine

North Campus Research Complex Building 14, 2800 Plymouth Rd Rm G016, Ann Arbor, MI 48109
(734) 615-8377

Snitkin Lab

1150 W Medical Center Dr, Ann Arbor, MI 48109
(734) 647-6472

Arbor Research Collaborative for Health

★ 4.8
2723 S State St Unit 150, Ann Arbor, MI 48104
(734) 665-4108

Towsley Center for Continuing Medical Education

★ 4.6
Ann Arbor, MI 48109
"The young lady at the desk right off parking structure should be more knowledgeable with directions."
— Lisa Rosenberry, 4★

Life Sciences Institute

★ 5.0
210 Washtenaw Ave, Ann Arbor, MI 48109
(734) 763-1200

Clinical trials in Ann Arbor: what's recruiting

The Ann Arbor area currently has 1,187 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Ann Arbor, the most active research areas are:

  • Cancer & Oncology11 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health2 studies
  • Lungs & Breathing2 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Ann Arbor, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Ann Arbor

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Ann Arbor participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Ann Arbor safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Ann Arbor, MI?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Ann Arbor?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Ann Arbor?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Ann Arbor.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Ann Arbor typically complete one or two studies per year.

Paid clinical trials near Ann Arbor

Other metros within reach

South Lyon, MI1,331 Toledo, OH212 Detroit, MI1,198 Flint, MI169 Lansing, MI172 Lorain, OH1,315 Fort Wayne, IN116 Kalamazoo, MI102

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Ann Arbor Chronic Kidney Disease (HealthMatch) in Ann Arbor Bladder Issues Due To Spinal Cord Injury in Ann Arbor All conditions

More of MI

South Lyon1,331 Detroit1,198 Grand Rapids466 Lansing172 Flint169 Kalamazoo102 Muskegon63

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts